Overview: LD 166, "An Act To Prohibit The Sale Of Tobacco Products In Pharmacies And Retail Establishments Containing Pharmacies", was signed into law by the Governor.
Purpose and Intent: The law aims to address the public health concerns around the sale of tobacco products in pharmacies and retail establishments with pharmacies. The rationale is that these locations, which are associated with healthcare and wellness, should not be promoting the sale of tobacco, which is a leading cause of preventable disease and death.
Key Provisions:
- Prohibits the sale of any tobacco product in pharmacies and retail establishments containing a pharmacy
- Defines "tobacco product" to include cigarettes, cigars, pipe tobacco, and other smokable, chewable, or vaporized tobacco products
- Provides exceptions for the sale of nicotine replacement therapy products approved by the FDA for smoking cessation
Affected Parties and Impacts: The law will impact pharmacies, retail stores with pharmacies, and tobacco product manufacturers and distributors by restricting the sale of their products in these locations. Consumers may need to seek tobacco products from other retail outlets.
Procedural and Timeline Considerations: The bill was signed into law by the Governor, and the new restrictions on tobacco sales in pharmacies and retail establishments containing pharmacies will take effect immediately.